Discrepant regulation of qt (qtc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 4, 2012, Pages 279-288

  Klimas, Jan ^a   Vaja, Vaclav ^a   Vercinska, Miriam ^a   Kyselovic, Jan ^a   Krenek, Peter ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; LACIDIPINE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART REPOLARIZATION; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; ENALAPRIL; HEART VENTRICLES; HYPERTENSION; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

RATTUS;

EID: 84866529989     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00901.x     Document Type: Article

References (46)

1. Fink M, Noble D Pharmacodynamic effects in the cardiovascular system: the modeller's view. Basic Clin Pharmacol Toxicol 2010;106:243-9.
2. Klimas J, Stankovicova T, Kyselovic J, Bacharova L Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin Exp Hypertens 2008;30:475-85.
3. Kmecova J, Klimas J Heart rate correction of the QT duration in rats. Eur J Pharmacol 2010;641:187-92.
4. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006;47:362-7.
5. Chapman N, Mayet J, Ozkor M, Lampe FC, Thom SA, Poulter NR QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am J Hypertens 2001;14:455-62.
6. Malmqvist K, Kahan T, Edner M, Bergfeldt L Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol: results from the SILVHIA study. J Hum Hypertens 2007;21:956-65.
7. Oikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K, Papademetriou V et al. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study. Am Heart J 2003;145:919-25.
8. Porthan K, Viitasalo M, Hiltunen TP, Vaananen H, Dabek J, Suonsyrja T et al. Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men. Ann Med 2009;41:29-37.
9. Dean JW, Lab MJ Regional changes in ventricular excitability during load manipulation of the in situ pig heart. J Physiol 1990;429:387-400.
10. Fogari R, Zoppi A, Maffioli P, Monti C, Lazzari P, Mugellini A et al. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus. Diabetes Obes Metab 2012;14:341-7.
11. Lim PO, Nys M, Naas AA, Struthers AD, Osbakken M, MacDonald TM Irbesartan reduces QT dispersion in hypertensive individuals. Hypertension 1999;33:713-8.
12. Matsuno Y, Minatoguchi S, Fujiwara H Effects of candesartan versus amlodipine on home-measured blood pressure, QT dispersion and left ventricular hypertrophy in high-risk hypertensive patients. Blood Press 2011;20(Suppl 1):12-9.
13. Grossman E, Messerli FH Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. Am J Cardiol 1997;80:1453-8.
14. Avdonin V, Shibata EF, Hoshi T Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes. J Gen Physiol 1997;109:169-80.
15. 2+ antagonists and agonists in rabbit cardiac myocytes. Am J Physiol 1991;260:H1737-42.
16. Delpon E, Caballero R, Gomez R, Nunez L, Tamargo J Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization. Trends Pharmacol Sci 2005;26:155-61.
17. Vaja V, Ochodnicky P, Krenek P, Klimas J, Bajuszova Z, Kyselovic J Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats. Eur J Pharmacol 2009;619:85-91.
18. Karas M, Lacourciere Y, LeBlanc AR, Nadeau R, Dube B, Florescu M et al. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens 2005;23:1251-60.
19. Givertz MM Manipulation of the renin-angiotensin system. Circulation 2001;104:E14-8.
20. Tsunoda M, Takezawa K, Santa T, Ina Y, Nagashima K, Ohmori K et al. New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats. Jpn J Pharmacol 2000;83:39-45.
21. de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB et al. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998;16:1357-69.
22. Hjemdahl P, Wallen NH Calcium antagonist treatment, sympathetic activity and platelet function. Eur Heart J 1997;18(Suppl A):A36-50.
23. Leenen FH, Myers MG, Joyner CD, Toal CB Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: nifedipine-GITS versus felodipine-ER versus enalapril. Can J Cardiol 2002;18:1285-93.
24. Krenek P, Morel N, Kyselovic J, Wibo M Amlodipine at high dose increases preproendothelin-1 expression in the ventricles and aorta of normotensive rats. J Hypertens 2004;22:827-35.
25. Mackovicova K, Gazova A, Kucerova D, Gajdacova B, Klimas J, Ochodnicky P et al. Enalapril decreases cardiac mass and fetal gene expression without affecting the expression of endothelin-1, transforming growth factor beta-1, or cardiotrophin-1 in the healthy normotensive rat. Can J Physiol Pharmacol 2011;89:197-205.
26. Aristizabal D, Messerli FH, Frohlich ED Disparate structural effects on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertension. Am J Cardiol 1994;73:483-7.
27. Barth W, Deten A, Bauer M, Reinohs M, Leicht M, Zimmer HG Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol 2000;32:273-84.
28. Kataoka C, Egashira K, Ishibashi M, Inoue S, Ni W, Hiasa K et al. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 2004;286:H768-74.
29. Dohi Y, Criscione L, Pfeiffer K, Luscher TF Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994;24:372-9.
30. Feletou M, Vanhoutte PM Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006;291:H985-1002.
31. Konishi M, Su C Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983;5:881-6.
32. Luscher TF, Vanhoutte PM Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986;8:344-8.
33. Torok J, Kristek F Functional and morphological pattern of vascular responses in two models of experimental hypertension. Exp Clin Cardiol 2001;6:142-8.
34. Krenek P, Salomone S, Kyselovic J, Wibo M, Morel N, Godfraind T Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats. Hypertension 2001;37:1124-8.
35. Baillard C, Mansier P, Ennezat PV, Mangin L, Medigue C, Swynghedauw B et al. Converting enzyme inhibition normalizes QT interval in spontaneously hypertensive rats. Hypertension 2000;36:350-4.
36. Dias da Silva VJ, Ferreira Neto E, Salgado HC, Fazan R Jr Chronic converting enzyme inhibition normalizes QT interval in aging rats. Braz J Med Biol Res 2002;35:1025-31.
37. Lamarre-Cliche M, Lacourciere Y, de Champlain J, Poirier L, Larochelle P Does QTc interval predict the response to beta-blockers and calcium channel blockers in hypertensives? Heart Dis 2003;5:244-52.
38. Takahara A, Nakamura Y, Wagatsuma H, Aritomi S, Nakayama A, Satoh Y et al. Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol 2009;158:1366-74.
39. van Wijk LM, van den Toren WE, van Gelder I, Crijns HJ, Ruegg P, Lie KI Electrophysiological properties of isradipine (PN200-110) in humans. J Cardiovasc Pharmacol 1989;14:492-5.
40. Cerbai E, Giotti A, Mugelli A Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes. Br J Pharmacol 1997;120:667-75.
41. Volders PG, Sipido KR, Vos MA, Spatjens RL, Leunissen JD, Carmeliet E et al. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 1999;100:2455-61.
42. Balasubramaniam R, Grace AA, Saumarez RC, Vandenberg JI, Huang CL Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 2003;552:535-46.
43. Thomas G, Gurung IS, Killeen MJ, Hakim P, Goddard CA, Mahaut-Smith MP et al. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3. J Physiol 2007;578:85-97.
44. Ishikawa T, Sugano T, Sumita S, Kimura K, Kikuchi M, Kosuge M et al. Relationship between atrioventricular delay, QT interval and cardiac function in patients with implanted DDD pacemakers. Europace 1999;1:192-6.
45. Wilcox JE, Rosenberg J, Vallakati A, Gheorghiade M, Shah SJ Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction. Am J Cardiol 2011;108:1760-6.
46. Vyas H, O'Leary PW, Earing MG, Cetta F, Ackerman MJ Mechanical dysfunction in extreme QT prolongation. J Am Soc Echocardiogr 2008;21:511.e15-e17.